TNSN99005A1 - Procede pour la preparation de naphtyridones, et intermediaires utilises - Google Patents

Procede pour la preparation de naphtyridones, et intermediaires utilises

Info

Publication number
TNSN99005A1
TNSN99005A1 TNTNSN99005A TNSN99005A TNSN99005A1 TN SN99005 A1 TNSN99005 A1 TN SN99005A1 TN TNSN99005 A TNTNSN99005 A TN TNSN99005A TN SN99005 A TNSN99005 A TN SN99005A TN SN99005 A1 TNSN99005 A1 TN SN99005A1
Authority
TN
Tunisia
Prior art keywords
preparation
naphtyridones
intermediates used
intermediates
trovafloxacin
Prior art date
Application number
TNTNSN99005A
Other languages
English (en)
Inventor
Kwok-Fung Chiu Charles
Theophilus Wint Lewin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99005A1 publication Critical patent/TNSN99005A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'INVENTION CONCERNE UN PROCEDE POUR LA PREPARATION D'UN COMPOSE DE FORMULE I PAR REDUCTION ET ACYLATION. ELLE CONCERNE EGALEMENT LES INTERMEDIAIRES UTILISES DANS CETTE PREPARATION. APPLICATION : PREPARATION DE TROVAFLOXACINE ET DE SES DERIVES.
TNTNSN99005A 1998-01-16 1999-01-13 Procede pour la preparation de naphtyridones, et intermediaires utilises TNSN99005A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7160198P 1998-01-16 1998-01-16

Publications (1)

Publication Number Publication Date
TNSN99005A1 true TNSN99005A1 (fr) 2005-11-10

Family

ID=22102373

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99005A TNSN99005A1 (fr) 1998-01-16 1999-01-13 Procede pour la preparation de naphtyridones, et intermediaires utilises

Country Status (39)

Country Link
EP (1) EP0930297B1 (fr)
JP (1) JPH11255745A (fr)
KR (1) KR19990067905A (fr)
CN (1) CN1228422A (fr)
AP (1) AP9901440A0 (fr)
AR (1) AR017228A1 (fr)
AT (1) ATE238281T1 (fr)
AU (1) AU9711598A (fr)
BG (1) BG64094B1 (fr)
BR (1) BR9900066A (fr)
CA (1) CA2258960C (fr)
DE (1) DE69907042T2 (fr)
DK (1) DK0930297T3 (fr)
EA (1) EA199900020A3 (fr)
EG (1) EG21514A (fr)
ES (1) ES2195513T3 (fr)
GT (1) GT199800199A (fr)
HR (1) HRP990013A2 (fr)
HU (1) HUP9900121A3 (fr)
ID (1) ID23612A (fr)
IL (1) IL127945A0 (fr)
IS (1) IS4943A (fr)
MA (1) MA24745A1 (fr)
NO (1) NO990185L (fr)
NZ (1) NZ333769A (fr)
OA (1) OA10955A (fr)
PA (1) PA8464701A1 (fr)
PE (1) PE20000172A1 (fr)
PL (1) PL330859A1 (fr)
PT (1) PT930297E (fr)
SA (1) SA99190971A (fr)
SG (1) SG76584A1 (fr)
SI (1) SI0930297T1 (fr)
SK (1) SK3899A3 (fr)
TN (1) TNSN99005A1 (fr)
TR (1) TR199900070A2 (fr)
TW (1) TW483890B (fr)
YU (1) YU1799A (fr)
ZA (1) ZA99277B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2049777C1 (ru) * 1989-08-16 1995-12-10 Пфайзер Инк. Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) * 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
US5475116A (en) * 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
DE19733439A1 (de) * 1997-08-02 1999-02-04 Bayer Ag Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften

Also Published As

Publication number Publication date
AP9901440A0 (en) 1999-03-31
EA199900020A2 (ru) 1999-08-26
ZA99277B (en) 2000-07-17
BG103087A (en) 1999-08-31
PT930297E (pt) 2003-08-29
SI0930297T1 (en) 2003-08-31
HUP9900121A3 (en) 2000-02-28
HUP9900121A2 (hu) 1999-09-28
DE69907042T2 (de) 2003-10-16
HU9900121D0 (en) 1999-03-29
IL127945A0 (en) 1999-11-30
SK3899A3 (en) 2000-03-13
CA2258960C (fr) 2002-09-03
ID23612A (id) 2000-05-04
CA2258960A1 (fr) 1999-07-16
EP0930297A1 (fr) 1999-07-21
YU1799A (sh) 2000-03-21
ES2195513T3 (es) 2003-12-01
PL330859A1 (en) 1999-07-19
BG64094B1 (bg) 2003-12-31
AR017228A1 (es) 2001-08-22
OA10955A (en) 2001-10-31
EA199900020A3 (ru) 1999-12-29
HRP990013A2 (en) 1999-10-31
MA24745A1 (fr) 1999-10-01
JPH11255745A (ja) 1999-09-21
DK0930297T3 (da) 2003-07-21
AU9711598A (en) 1999-08-05
GT199800199A (es) 2000-06-07
TW483890B (en) 2002-04-21
BR9900066A (pt) 2000-05-09
EP0930297B1 (fr) 2003-04-23
NZ333769A (en) 2000-03-27
NO990185L (no) 1999-07-19
CN1228422A (zh) 1999-09-15
TR199900070A3 (tr) 1999-10-21
DE69907042D1 (de) 2003-05-28
KR19990067905A (ko) 1999-08-25
IS4943A (is) 1999-07-17
TR199900070A2 (xx) 1999-10-21
ATE238281T1 (de) 2003-05-15
EG21514A (en) 2001-11-28
PA8464701A1 (es) 2000-09-29
PE20000172A1 (es) 2000-03-09
SG76584A1 (en) 2000-11-21
SA99190971A (ar) 2005-12-03
NO990185D0 (no) 1999-01-15

Similar Documents

Publication Publication Date Title
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN97070A1 (fr) Derives d'imidazole substitues, procede pour leur preparation, et compositions les contenant
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
AU7027987A (en) Conjugate compound
BRPI9917739B8 (pt) composto intermediário na preparação de inibidores de cox-2
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN00202A1 (fr) Derives de n-[(purine - 2- yl) methyl]-sulfonamide nouveaux, procede pour leur preparation et compositions les contenant
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
MA27883A1 (fr) Derives de pyrido [2,1-a] isoquinoline utilises comme inhibiteurs de dpp-iv
TNSN98150A1 (fr) Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant
BR0011436A (pt) Complexos metálicos de poliaminoacidos bicìclicos, seu processo de preparação e sua aplicação em formação de imagem médica
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
EP1101755A4 (fr) Derives d'acide anthranilique
FR2770216B1 (fr) Procede d'obtention de la forme polymorphe epsilon de l'hexanitrohexaazaisowurtzitane
TNSN99189A1 (fr) Procede pour la preparation de pyrazolo (4,3-d) pyrimidine-7- ones, et intermediaires pour ce procede
WO2000076489A3 (fr) Procede d'inhibition de l'agregation de proteines amyloides et de formation d'images de depots amyloides
MA21902A1 (fr) Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant .
UA66866C2 (uk) Синтез морфолінових похідних
TNSN99005A1 (fr) Procede pour la preparation de naphtyridones, et intermediaires utilises
DZ2430A1 (fr) Procédé pour la préparation de dérivés de thiazolidinedione substitués.
ES2136799T3 (es) Benzotiofenos de glucopiranosido.
TNSN00195A1 (fr) PROCEDE POUR LA PREPARATION DE DERIVES DE PYRAZOLO [4,3-d] PYRIMIDINE-7-ONE-3-PYRIDYLSULFONYLE, ET INTERMEDIAIRES UTILISES
DZ2619A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués.
FR2749006B1 (fr) Procede pour la fabrication d'une solution aqueuse industrielle de chlorure de sodium
DZ2423A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués.